Quang X. Pham, CEO and Chairman, 10% Owner at Cadrenal Therapeutics, Inc. (CVKD), sold 3,600 shares at $14.15 ($51K) on 2025-10-13, disclosed to the SEC on 2025-10-14.
Scheduled sale ($51k) by CEO and Chairman, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.02 | 1,800 | $25K | 49.8% |
| 2 | $14.15 | 1,800 | $25K | 50.2% |
| Total | $14.09 avg | 3,600 | $51K | 100% |
| Filing → |
| CVKD | SELL | 2026-06-24 | $40K | — | Filing → |
| CVKD | SELL | 2026-06-18 | $13K | — | Filing → |
| CVKD | SELL | 2026-06-15 | $70K | — | Filing → |